REFERENCES
- Seeler RA. Parahemophilia: factor V deficiency. Med Clin North Am 1972;56:119–25
- Mammen EF. Factor V deficiency. Semin Thromb Hemost 1983;9:1–72
- Lak M, Sharifian R, Peyvandi F, et at. Symptoms of inherited factor V deficiency in 35 Iranian patients. Br J Haernatol 1998;103:1067–9
- Manotti C, Qunitavalle R, Pini M, et at. Thromboembolic manifestations and congenital V deficiency: a family study. Haemostasis 1989;19:331–4
- Phillips LL, Little WA. Factor V deficiency in obstetrics. Obstet G ynecol 1962;19:507–12
- Noia G, De Carolis S, De Stefano V, et at. Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature. Blood Coagul Fibrinolysis 1997;76:890–2
- Caldwell DC, Williamson RA, Goldsmith JC. Hereditary coagulopathies in pregnancy. Clin Obstet G ynecol 1985;28:53–72
- Hellstem P, Sachse H, Schwinn H, et at. Manufacture and in vitro characterization of a solvent/detergent-treated human plasma. Vox Sang 1992; 3:178–85
- Williamson LM, Allain JP. Virally inactivated fresh frozen plasma. Vox Sang 1995;69:159–65
- Biesert L, Suhartono H. Solvent/detergent treatment of human plasma - a very robust method for virus inactivation. Validated virus safety of Ocatplas6. Vox Sang 1998;74( Suppl 1):207–12
- Solheim BG, Rollag H, Svennevig JL, et at. Viral safety of solvent/detergent-treated plasma. Transfusion 2000;40:84–90
- Inbal A, Epstein O, Blickstein D, et at. Evaluation of solvent/ detergent treated plasma in the management of patients with hereditary and acquired coagulation disorders. Blood Coagul Fibrinolysis 1993;4:599–604
- Doyle S, O'Brien P, Murphy K, et al. Coagulation factor content of solvent/detergent plasma compared to fresh frozen plasma. Blood Coagul Fibrinolysis 2003;14:283–7